Benefit risk assessment and update on the use of docetaxel in the management of breast cancer
Scheryll Alken, Catherine M KellyDepartment of Medical Oncology, Mater Misericordiae University Hospital, Dublin, IrelandAbstract: The objective of this paper is to review the data supporting the use of docetaxel in the treatment of breast cancer, focusing on pharmacokinetics, efficacy in adjuvant a...
Main Authors: | Alken S, Kelly CM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-10-01
|
Series: | Cancer Management and Research |
Online Access: | http://www.dovepress.com/benefit-risk-assessment-and-update-on-the-use-of-docetaxel-in-the-mana-a14686 |
Similar Items
-
Presentation and management of docetaxel-related adverse effects in patients with breast cancer
by: Ho MY, et al.
Published: (2014-05-01) -
Molecular mechanisms of docetaxel resistance in breast cancer
by: Kastl, Lena
Published: (2007) -
PHARMACOECONOMIC ANALYSIS OF DOCETAXEL IN THE ADJUVANT THERAPY OF BREAST CANCER
by: R. I. Yagudina, et al.
Published: (2015-03-01) -
Trastuzumab-Coated Nanoparticles Loaded With Docetaxel for Breast Cancer Therapy
by: Xueyan Zhang, et al.
Published: (2019-09-01) -
Relationship Between Docetaxel AUC and Neutropenia in Patients with Breast Cancer
by: ZHANG Ni, et al.
Published: (2018-05-01)